INTRODUCING…

The only non-invasive, rapid Point-of-Care test for Allergic Conjunctivitis (AC)

Every year, millions of people visit their doctors seeking relief from “pink eye”, also known as ocular conjunctivitis. The diagnosis can be difficult because the symptoms are often the same whether the cause is a virus, bacterium, or allergen. Allereye™ helps physicians make a quick and confident diagnosis. The Allergic Conjunctivitis diagnosis can prevent unnecessary dry-eye treatment and/or antibiotic prescription.

Allereye Logo Bluejay Diagnostics

About Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc., headquartered in Acton, Massachusetts, is a clinical stage diagnostic company focused on the development, manufacturing, sales, and marketing of non-invasive, point-of-care (“POC”) tests and devices that provide patients and providers with access to affordable and timely healthcare. The Company’s flagship product, a POC test for Allergic Conjunctivitis, Allereye™ is currently undergoing clinical trials with an expected launch in late 2017.



NEWS

Bluejay Diagnostics Douglas Wurth

May 22, 2017

BLUEJAY DIAGNOSTICS’ BOARD OF DIRECTORS ANNOUNCES APPOINTMENT OF DOUGLAS C. WURTH AS CHAIRMAN

Bluejay Diagnostics, Inc. today announced that its board of directors unanimously named Douglas C. Wurth as the Company’s chairman, effective immediately.


Allereye Tear Total IgE Kit

February 27, 2017

BLUEJAY DIAGNOSTICS, INC. ANNOUNCES CLINICAL RESEARCH COLLABORATION TO DEVELOP POINT OF CARE TEST FOR ALLERGIC CONJUNCTIVITIS

Bluejay Diagnostics, Inc. (today announced a collaborative clinical research agreement with Hitachi Chemical Co., Ltd. (Hitachi Chemical) to develop a non-invasive, point-of-care test that measures total IgE in human tears.